Cantitate/Preț
Produs

The International Consensus Classification of Myeloid and Lymphoid Neoplasms

Autor Daniel A Arber
en Limba Engleză Hardback – 11 ian 2025

Developed by 149 experts in the field, The International Consensus Classification of Myeloid and Lymphoid Neoplasms provides key information for use at the microscope to assist in arriving at a swift and accurate diagnosis. Drs. Daniel Arber, Michael J. Borowitz, James Cook, Laurence de Leval, John Goodlad, Robert Hasserjian, Rebecca L. King, Hans-Michael Kvasnicka, and Attilio Orazi lead a team of authors who focus on diagnostic criteria and the clinical significance of each disease entity.
 

  • Offers up-to-date information developed through a Clinical Advisory Committee (CAC) process that included the authors and editors of the former 3rd, 4th, and revised 4th edition World Health Organization (WHO) classification of hematopoietic and lymphoid tumors
  • Focuses on diagnostic criteria and includes guidelines as to the clinical significance of each disease authored by a clinician expert
  • Provides essential information for pathologists and hematopathologists in practice and in training, as well as oncologists and hematologists who want to better understand the many disease categories that they encounter

,

Citește tot Restrânge

Preț: 90787 lei

Preț vechi: 129743 lei
-30% Nou

Puncte Express: 1362

Preț estimativ în valută:
16066 18735$ 14106£

Carte disponibilă

Livrare economică 26 decembrie 25 - 07 ianuarie 26
Livrare express 11-17 decembrie pentru 19914 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781975222598
ISBN-10: 1975222598
Pagini: 768
Dimensiuni: 222 x 284 x 40 mm
Greutate: 2.56 kg
Ediția:First
Editura: Lippincott Williams&Wilki

Descriere

Developed by 149 experts in the field, The International Consensus Classification of Myeloid and Lymphoid Neoplasms provides key information for use at the microscope to assist in arriving at a swift and accurate diagnosis. Drs. Daniel Arber, Michael J. Borowitz, James Cook, Laurence de Leval, John Goodlad, Robert Hasserjian, Rebecca L. King, Hans-Michael Kvasnicka, and Attilio Orazi lead a team of authors who focus on diagnostic criteria and the clinical significance of each disease entity.